Photo from c4therapeutics.com
Jun 11, 2023, 07:50
Targeting Myc is a rational strategy – Hagop Youssoufian
Happy to share with you our poster that we presented this weekend at the European Hematology Association meeting in Frankfurt on a new potential treatment for Burkitt’s lymphoma, a highly aggressive subtype of lymphoma that was initially described in 1957! To date there is no specific therapy for this disease. Targeting Myc is a rational strategy. This study represents an ongoing and fruitful collaboration between Cothera Bioscience, Inc., and a multinational group of investigators led by Dr. S-S Yoon and his team from Seoul National University Hospital , Seoul, Korea.
https://clin.larvol.com/abstract-detail/EHA%202023/65462943
Source: Hagop Youssoufian / LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 15:17
Nov 19, 2024, 15:17
Nov 19, 2024, 15:14
Nov 19, 2024, 15:12
Nov 19, 2024, 14:54
Nov 19, 2024, 14:42
Nov 19, 2024, 14:20
Nov 19, 2024, 14:01
Nov 19, 2024, 14:00